ARDX vs. PACB
ARDX (Ardelyx, Inc.) and PACB (Pacific Biosciences of California, Inc.) are both stocks. Both are in the Healthcare sector — ARDX in Biotechnology, PACB in Diagnostics & Research. Over the past 10 years, ARDX returned -2.60%/yr vs -16.69%/yr for PACB. At a 0.26 correlation, their price movements are largely independent.
Performance
ARDX vs. PACB - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, ARDX achieves a 6.00% return, which is significantly higher than PACB's -29.95% return. Over the past 10 years, ARDX has outperformed PACB with an annualized return of -2.60%, while PACB has yielded a comparatively lower -16.69% annualized return.
ARDX
- 1D
- -2.98%
- 1M
- 1.15%
- YTD
- 6.00%
- 6M
- 6.55%
- 1Y
- 70.25%
- 3Y*
- 19.74%
- 5Y*
- -4.70%
- 10Y*
- -2.60%
PACB
- 1D
- -0.76%
- 1M
- 7.38%
- YTD
- -29.95%
- 6M
- -28.02%
- 1Y
- 10.08%
- 3Y*
- -52.85%
- 5Y*
- -47.38%
- 10Y*
- -16.69%
ARDX vs. PACB - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
ARDX Ardelyx, Inc. | 6.00% | 14.99% | -18.23% | 117.54% | 159.09% | -83.00% | -13.79% | 319.27% | -72.88% | -53.52% |
PACB Pacific Biosciences of California, Inc. | -29.95% | 2.19% | -81.35% | 19.93% | -60.02% | -21.13% | 404.67% | -30.54% | 180.30% | -30.53% |
Correlation
The correlation between ARDX and PACB is 0.23, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.23 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.25 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.31 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.27 |
Correlation (All Time) Calculated using the full available price history since Jun 19, 2014 | 0.26 |
Fundamentals
ARDX:
$1.52B
PACB:
$400.62M
ARDX:
-$0.24
PACB:
-$0.43
ARDX:
3.51
PACB:
2.47
ARDX:
10.22
PACB:
3.82
ARDX:
$427.68M
PACB:
$160.03M
ARDX:
$395.63M
PACB:
$59.34M
ARDX:
-$28.55M
PACB:
-$146.34M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ARDX vs. PACB — Risk / Return Rank
ARDX
PACB
ARDX vs. PACB - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Ardelyx, Inc. (ARDX) and Pacific Biosciences of California, Inc. (PACB). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| ARDX | PACB | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.03 | ||
| Sortino ratioReturn per unit of downside risk | +1.29 | ||
| Omega ratioGain probability vs. loss probability | 1.26 | 1.09 | +0.16 |
| Calmar ratioReturn relative to maximum drawdown | 2.11 | 0.17 | +1.93 |
| Martin ratioReturn relative to average drawdown | 4.07 | 0.32 | +3.75 |
Loading charts...
Drawdowns
ARDX vs. PACB - Drawdown Comparison
The maximum ARDX drawdown since its inception was -98.45%, roughly equal to the maximum PACB drawdown of -98.22%. Use the drawdown chart below to compare losses from any high point for ARDX and PACB.
Loading charts...
Drawdown Indicators
| ARDX | PACB | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -98.45% | -98.22% | -0.23% |
Max Drawdown (1Y)Largest decline over 1 year | -33.54% | -58.05% | +24.51% |
Max Drawdown (3Y)Largest decline over 3 years | -66.32% | -93.47% | +27.15% |
Max Drawdown (5Y)Largest decline over 5 years | -93.76% | -97.47% | +3.71% |
Max Drawdown (10Y)Largest decline over 10 years | -96.82% | -98.22% | +1.40% |
Current DrawdownCurrent decline from peak | -81.21% | -97.44% | +16.23% |
Average DrawdownAverage peak-to-trough decline | -77.37% | -70.57% | -6.80% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 17.31% | 31.59% | -14.28% |
Volatility
ARDX vs. PACB - Volatility Comparison
The current volatility for Ardelyx, Inc. (ARDX) is 12.95%, while Pacific Biosciences of California, Inc. (PACB) has a volatility of 22.24%. This indicates that ARDX experiences smaller price fluctuations and is considered to be less risky than PACB based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ARDX | PACB | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 12.95% | 22.24% | -9.29% |
Volatility (6M)Calculated over the trailing 6-month period | 46.39% | 56.24% | -9.85% |
Volatility (1Y)Calculated over the trailing 1-year period | 61.42% | 87.49% | -26.07% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 89.49% | 94.44% | -4.95% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 83.99% | 84.70% | -0.71% |
Dividends
ARDX vs. PACB - Dividend Comparison
Neither ARDX nor PACB has paid dividends to shareholders.
Financials
ARDX vs. PACB - Financials Comparison
This section allows you to compare key financial metrics between Ardelyx, Inc. and Pacific Biosciences of California, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
ARDX and PACB have a correlation of 0.23, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
PACB has higher volatility (22.24%) compared to ARDX (12.95%). In terms of maximum drawdown, ARDX dropped -98.45% vs PACB's -98.22%.
ARDX currently has the higher Sharpe Ratio (1.15 vs 0.12), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for ARDX and PACB
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer